Topical JAK inhibitors, phototherapy, and combination strategies now anchor first-line vitiligo treatment. Drs. Desai and ...

Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.

Selection approaches were highly heterogeneous, limiting cross-study comparability and underscoring the absence of a ...

Vitiligo care rarely stays within dermatology alone. The panel discusses when to loop in primary care, endocrinology, ...

Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts ...

Early planning for third-line therapy, guided by subtle clinical and biochemical signals, now shapes how oncologists ...

People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.

Invivyd presented preclinical IDWeek 2026 data on VMS063, an investigational antibody that neutralized B3 and D8 measles variants in vitro.

Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review ...

Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets ...

Crescent Moore, PharmD, PhD, discusses provider, coverage, stigma, and education barriers to menopause therapy access.

Unresolved questions about immunotherapy duration, right-sided tumor biology, and earlier use of targeted agents illustrate ...